266 related articles for article (PubMed ID: 24818768)
1. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.
Mai J; Huang Y; Mu C; Zhang G; Xu R; Guo X; Xia X; Volk DE; Lokesh GL; Thiviyanathan V; Gorenstein DG; Liu X; Ferrari M; Shen H
J Control Release; 2014 Aug; 187():22-9. PubMed ID: 24818768
[TBL] [Abstract][Full Text] [Related]
2. Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting.
Mann AP; Somasunderam A; Nieves-Alicea R; Li X; Hu A; Sood AK; Ferrari M; Gorenstein DG; Tanaka T
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927342
[TBL] [Abstract][Full Text] [Related]
3. E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow.
Mann AP; Tanaka T; Somasunderam A; Liu X; Gorenstein DG; Ferrari M
Adv Mater; 2011 Sep; 23(36):H278-82. PubMed ID: 21833996
[No Abstract] [Full Text] [Related]
4. Thioaptamer conjugated liposomes for tumor vasculature targeting.
Mann AP; Bhavane RC; Somasunderam A; Liz Montalvo-Ortiz B; Ghaghada KB; Volk D; Nieves-Alicea R; Suh KS; Ferrari M; Annapragada A; Gorenstein DG; Tanaka T
Oncotarget; 2011 Apr; 2(4):298-304. PubMed ID: 21666286
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
[TBL] [Abstract][Full Text] [Related]
6. High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.
Shen J; Xu R; Mai J; Kim HC; Guo X; Qin G; Yang Y; Wolfram J; Mu C; Xia X; Gu J; Liu X; Mao ZW; Ferrari M; Shen H
ACS Nano; 2013 Nov; 7(11):9867-80. PubMed ID: 24131405
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
[TBL] [Abstract][Full Text] [Related]
8. E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis.
Ma S; Tian XY; Zhang Y; Mu C; Shen H; Bismuth J; Pownall HJ; Huang Y; Wong WT
Sci Rep; 2016 Mar; 6():22910. PubMed ID: 26956647
[TBL] [Abstract][Full Text] [Related]
9. Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.
Kang SA; Hasan N; Mann AP; Zheng W; Zhao L; Morris L; Zhu W; Zhao YD; Suh KS; Dooley WC; Volk D; Gorenstein DG; Cristofanilli M; Rui H; Tanaka T
Mol Ther; 2015 Jun; 23(6):1044-1054. PubMed ID: 25815697
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
11. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration.
Zen K; Liu DQ; Guo YL; Wang C; Shan J; Fang M; Zhang CY; Liu Y
PLoS One; 2008 Mar; 3(3):e1826. PubMed ID: 18350162
[TBL] [Abstract][Full Text] [Related]
12. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
[TBL] [Abstract][Full Text] [Related]
13. Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.
Shen H; Rodriguez-Aguayo C; Xu R; Gonzalez-Villasana V; Mai J; Huang Y; Zhang G; Guo X; Bai L; Qin G; Deng X; Li Q; Erm DR; Aslan B; Liu X; Sakamoto J; Chavez-Reyes A; Han HD; Sood AK; Ferrari M; Lopez-Berestein G
Clin Cancer Res; 2013 Apr; 19(7):1806-15. PubMed ID: 23386691
[TBL] [Abstract][Full Text] [Related]
14. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
Shamay Y; Golan M; Tyomkin D; David A
J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
[TBL] [Abstract][Full Text] [Related]
15. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
[TBL] [Abstract][Full Text] [Related]
16. The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
[TBL] [Abstract][Full Text] [Related]
17. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
[TBL] [Abstract][Full Text] [Related]
18. A systematic comparison of lipopolymers for siRNA delivery to multiple breast cancer cell lines: In vitro studies.
Aliabadi HM; Bahadur K C R; Bousoik E; Hall R; Barbarino A; Thapa B; Coyle M; Mahdipoor P; Uludağ H
Acta Biomater; 2020 Jan; 102():351-366. PubMed ID: 31760224
[TBL] [Abstract][Full Text] [Related]
19. DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement.
Mai J; Li X; Zhang G; Huang Y; Xu R; Shen Q; Lokesh GL; Thiviyanathan V; Chen L; Liu H; Zu Y; Ma X; Volk DE; Gorenstein DG; Ferrari M; Shen H
Mol Pharm; 2018 May; 15(5):1814-1825. PubMed ID: 29537266
[TBL] [Abstract][Full Text] [Related]
20. Transient mild hyperthermia induces E-selectin mediated localization of mesoporous silicon vectors in solid tumors.
Kirui DK; Mai J; Palange AL; Qin G; van de Ven AL; Liu X; Shen H; Ferrari M
PLoS One; 2014; 9(2):e86489. PubMed ID: 24558362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
